Exploring Novel Gene Mutations Associated with Fluoroquinolone Resistance in Mycobacterium tuberculosis: Gene Sequencing Results from 275 Clinical Isolates in Chongqing, China

Xiaoman Zheng,1,* Tingting Zhou,1,* Rong Zeng,2 Yanqiu Lu,1 Sen Yang,1 Jing Ouyang,1 Jintian Xu,2 Jifang Yu,2 Jiaoyu Deng,2 Yaokai Chen1 1Clinical Research Center, Chongqing Public Health Medical Center, Chongqing, People’s Republic of China; 2Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yaokai Chen, Email [email protected] Jiaoyu Deng, Email [email protected]: This study aimed to investigate whether mutations in the rv2005c, PPE59, and recC genes are associated with fluoroquinolone (FQ) resistance in Mycobacterium tuberculosis (Mtb), particularly in strains lacking mutations in the known resistance genes gyrA and gyrB.Methods: A total of 275 clinical isolates, consisting of 217 pre-extensively drug-resistant strains and 58 fluoroquinolone-sensitive strains, were included in this study. Gene sequencing was performed on all isolates, and functional assessments through both overexpression and knockout experiments of the gene were conducted to evaluate its effect on fluoroquinolone susceptibility.Results: Results: Among 275 isolates, no mutations were detected in PPE59 or recC. In the 217 pre-XDR isolates, gyrA mutations were found in 214 (98.6%), predominantly at codons 94, 90, and 91. Only two isolates harbored synonymous mutations in rv2005c (P235P), both with concurrent gyrA D94G mutations. Overexpression or knockout of rv2005c in Mtb did not alter FQ susceptibility. Notably, two FQ-resistant isolates lacked mutations in any of the five genes sequenced, suggesting the presence of unknown resistance mechanisms.Conclusion: Our results showed that mutations of the rv2005c, PPE59 and recC genes may not contribute to FQ resistance in clinical isolates of Mtb in Chongqing, China. Furthermore, our study results also showcased the complexity of mechanisms of FQ resistance in clinical Mtb isolates.Keywords: Mycobacterium tuberculosis, fluoroquinolone resistance, drug susceptibility, gene mutations, mechanism

Authors

Institutions

Publication Details

Journal
DOAJ (DOAJ: Directory of Open Access Journals)
Published
2026-04-01
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring Novel Gene Mutations Associated with Fluoroquinolone Resistance in Mycobacterium tuberculosis: Gene Sequencing Results from 275 Clinical Isolates in Chongqing, China

Yu J, Deng J, Yang S, Zheng X et al.
DOAJ (DOAJ: Directory of Open Access Journals)
Tuberculosis Research and Epidemiology
article

Exploring Novel Gene Mutations Associated with Fluoroquinolone Resistance in Mycobacterium tuberculosis: Gene Sequencing Results from 275 Clinical Isolates in Chongqing, China

Yu J, Deng J, Yang S, Zheng X, Chen Y, Zeng R, Lu Y, Zhou T, Xu J, Ouyang J
article en

Abstract

Xiaoman Zheng,1,* Tingting Zhou,1,* Rong Zeng,2 Yanqiu Lu,1 Sen Yang,1 Jing Ouyang,1 Jintian Xu,2 Jifang Yu,2 Jiaoyu Deng,2 Yaokai Chen1 1Clinical Research Center, Chongqing Public Health Medical Center, Chongqing, People’s Republic of China; 2Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yaokai Chen, Email [email protected] Jiaoyu Deng, Email [email protected]: This study aimed to investigate whether mutations in the rv2005c, PPE59, and recC genes are associated with fluoroquinolone (FQ) resistance in Mycobacterium tuberculosis (Mtb), particularly in strains lacking mutations in the known resistance genes gyrA and gyrB.Methods: A total of 275 clinical isolates, consisting of 217 pre-extensively drug-resistant strains and 58 fluoroquinolone-sensitive strains, were included in this study. Gene sequencing was performed on all isolates, and functional assessments through both overexpression and knockout experiments of the gene were conducted to evaluate its effect on fluoroquinolone susceptibility.Results: Results: Among 275 isolates, no mutations were detected in PPE59 or recC. In the 217 pre-XDR isolates, gyrA mutations were found in 214 (98.6%), predominantly at codons 94, 90, and 91. Only two isolates harbored synonymous mutations in rv2005c (P235P), both with concurrent gyrA D94G mutations. Overexpression or knockout of rv2005c in Mtb did not alter FQ susceptibility. Notably, two FQ-resistant isolates lacked mutations in any of the five genes sequenced, suggesting the presence of unknown resistance mechanisms.Conclusion: Our results showed that mutations of the rv2005c, PPE59 and recC genes may not contribute to FQ resistance in clinical isolates of Mtb in Chongqing, China. Furthermore, our study results also showcased the complexity of mechanisms of FQ resistance in clinical Mtb isolates.Keywords: Mycobacterium tuberculosis, fluoroquinolone resistance, drug susceptibility, gene mutations, mechanism

DOAJ (DOAJ: Directory of Open Access Journals)
Wuhan Institute of Virology (CN), Clinical Research Management (US)
Good health and well-being
Openalex Percentile: Top 24%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.